Biocompatible nanoparticle and use thereof

US10954348B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10954348-B2
Application numberUS-201816040871-A
CountryUS
Kind codeB2
Filing dateJul 20, 2018
Priority dateJan 20, 2016
Publication dateMar 23, 2021
Grant dateMar 23, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a biocompatible nanoparticle and a use thereof and, more specifically, to a biocompatible nanoparticle formed by irradiation an electron beam to an aqueous solution comprising at least one substance selected from the group consisting of a polysaccharide, a derivative thereof and a polyethylene glycol, thereby inducing inter-molecular cross-linking or intra-molecular cross-linking, and to a use of the biocompatible nanoparticle in a drug carrier, a contrast agent, a diagnostic agent or an intestinal adhesion prevention agent or for disease prevention and treatment.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preparing biocompatible nanoparticles, the method comprising: (a) adding to water, at least one material selected from the group consisting of polysaccharides, and a mixture of a polysaccharide and polyethylene glycol to prepare a 0.1% (w/v) to 15% (w/v) solution; and (b) irradiating the solution prepared in step (a) with an electron beam at a dose of 5 to 250 kGy to crosslink the material, wherein the biocompatible nanoparticle is formed exclusively by inter-molecular or intra-molecular crosslinking of at least one selected from the group consisting of a polysaccharide, and a mixture of a polysaccharide and polyethylene glycol, wherein the method excludes the use of a crosslinking agent, a curing agent, an inorganic material, and an organic solvent, wherein the polysaccharide is at least one selected from the group consisting of mannan, α-cyclodextrin, β-cyclodextrin, γ-cyclodextrin, fructo-oligosaccharides, isomalto-oligosaccharides, inulin, glycogen, amylose, carboxymethyl dextran, beta-glucan, fucoidan, and chondroitin, wherein a size of the nanoparticle is in a range of 1 to 700 nm.

Assignees

Inventors

Classifications

  • Reserve carbohydrates, e.g. glycogen, inulin, laminarin; Derivatives thereof (not used) · CPC title

  • Ethers · CPC title

  • conjugates with carriers being macromolecules · CPC title

  • Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof · CPC title

  • Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10954348B2 cover?
The present invention relates to a biocompatible nanoparticle and a use thereof and, more specifically, to a biocompatible nanoparticle formed by irradiation an electron beam to an aqueous solution comprising at least one substance selected from the group consisting of a polysaccharide, a derivative thereof and a polyethylene glycol, thereby inducing inter-molecular cross-linking or intra-molec…
Who is the assignee on this patent?
Kyungpook Nat Univ Ind Academic Coop Found
What technology area does this patent fall under?
Primary CPC classification A61K47/56. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).